medRxiv

Social Determinants of Health and GLP-1 RA Use Among Patients with Type 2 Diabetes and Stage 2 CKM: Insights from NHANES 2005?2020

By Qi Jian, Mark S. Segal, Hui Shao, Naikky V Singh-Ospina, Tianze Jiao

Preprint: study in peoplePopulations

The paper

Qi Jian, Mark S. Segal, Hui Shao, Naikky V Singh-Ospina, Tianze Jiao

University of Florida

medRxiv, 21 Aug 2026, CC BY-NC-ND, Preprint, not peer-reviewed

doi.org/10.64898/2026.08.18.26360763

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
medRxiv4 Oct 2026
Social context predicts heart risks despite normal biomarkers